Fortune March 26, 2020
E. Richard Gold

If, like me, you need a mental break from the COVID-19 pandemic, let’s take an excursion to the future, when we emerge from it. Specifically, let’s think about how the world can build on this moment to develop a more open and effective drug discovery system: a system that will allow us to develop vaccines and treatments not only for future pandemics, but also for the pandemics of heart disease, cancer, and brain and nervous system diseases that already exist.

What has been percolating for a while is that the global drug discovery system is increasingly unsustainable. U.S. consumers see this in significantly escalating prices for common drugs—such as insulin, EpiPens, and Humira—but the problem is much deeper. According...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Technology, Trends
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth

Share This Article